Form 4: Edwards Lifesciences CFO Reports Stock Disposition

CFO Scott B. Ullem disposed of 3,034 shares of Edwards Lifesciences common stock to cover tax obligations.

Summary

• Scott B. Ullem, CVP and Chief Financial Officer of Edwards Lifesciences, reported the disposition of 3,034 shares of common stock.
• The transactions occurred on May 7, 2026 (1,373 shares at $83.20) and May 8, 2026 (1,661 shares at $82.76).
• The shares were withheld by the issuer to satisfy tax withholding obligations related to the vesting of equity awards.
• Following these transactions, the reporting person maintains direct ownership of 37,914 shares and indirect ownership of 266,318 shares held in a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event, as the share reduction was purely for tax compliance purposes.

Positives

• The reporting person maintains a significant long-term stake in the company, with 266,318 shares held indirectly via trust.

Negatives

• The filing reflects a reduction in direct share ownership, though this is attributed to mandatory tax withholding rather than a discretionary sale.

Risks

• None identified; this is a routine administrative transaction related to tax obligations.

Future Outlook

Not applicable; this is a retrospective disclosure of a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that routine tax-related share withholding by executives is a standard corporate practice and does not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity compensation tax withholding.
• The retention of a large indirect trust position is consistent with long-term executive alignment with shareholder interests.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a routine tax-related withholding.

Next Steps

• No future actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

Edwards Lifesciences, EW, Insider Trading, Form 4, CFO, Stock Disposition